An equine thermal therapy overleg device that encircles a pastern of a subject horse and provides thermal therapy to the subject horse. The may include a pastern dual layer component, a distal phalanx cover and a distal phalanx slipper. The arrangement of the pastern dual layer component, a distal phalanx cover and a distal phalanx slipper allow for free movement of the subject horse and for a thermal fluid to contain ice and prevent the ice from becoming lodged around the subject horse hoof.

An equine thermal therapy overleg device that encircles a pastern of a subject horse and provides thermal therapy to the subject horse. The may include a pastern dual layer component, a distal phalanx cover and a distal phalanx slipper. The arrangement of the pastern dual layer component, a distal phalanx cover and a distal phalanx slipper allow for free movement of the subject horse and for a thermal fluid to contain ice and prevent the ice from becoming lodged around the subject horse hoof.

Elastic polymer compositions that provide stretch recovery to absorbent fabrics and products produced from these absorbent fabrics and methods for their production are provided.

Elastic polymer compositions that provide stretch recovery to absorbent fabrics and products produced from these absorbent fabrics and methods for their production are provided.

The invention relates to a plaster for use in the context of an intramuscular injection, particularly a vaccination, having a patient side and an outer side, comprising: an adhesive layer on the patient side for attaching the plaster to the skin of a patient, an absorbent wound-covering on the patient side in the region of an intended intramuscular injection site, the absorbent wound-covering having received a disinfectant, and an opening on the outer side in the area of the absorbent wound-covering of the patient side for the injection needle.

The invention relates to a plaster for use in the context of an intramuscular injection, particularly a vaccination, having a patient side and an outer side, comprising: an adhesive layer on the patient side for attaching the plaster to the skin of a patient, an absorbent wound-covering on the patient side in the region of an intended intramuscular injection site, the absorbent wound-covering having received a disinfectant, and an opening on the outer side in the area of the absorbent wound-covering of the patient side for the injection needle.

Disclosed embodiments relate to a wound contact layer in the form of a perforated film, possessing one or more of the following functions: speed of kill, sustained kill, broad-spectrum kill against microorganisms, one-piece removal, conformability with a wound surface, compatibility with negative pressure wound treatment, exudate management, autolytic debridement, and self-indicating of changes. The wound contact layer comprises a biocompatible polymeric matrix and, embedded in the matrix, fluid-absorbent particles loaded with therapeutics. The matrix comprises a mixture of an elastomeric composition and a hydrophilic polymer. The film is perforated with an array of holes. A desired loading of therapeutics in the wound contact layer may be tuned by varying the amount of therapeutics loaded within the fluid-absorbent particles, the density of the fluid-absorbent particles within the wound contact layer, the perforation size, and the thickness of the wound contact layer.

Disclosed embodiments relate to a wound contact layer in the form of a perforated film, possessing one or more of the following functions: speed of kill, sustained kill, broad-spectrum kill against microorganisms, one-piece removal, conformability with a wound surface, compatibility with negative pressure wound treatment, exudate management, autolytic debridement, and self-indicating of changes. The wound contact layer comprises a biocompatible polymeric matrix and, embedded in the matrix, fluid-absorbent particles loaded with therapeutics. The matrix comprises a mixture of an elastomeric composition and a hydrophilic polymer. The film is perforated with an array of holes. A desired loading of therapeutics in the wound contact layer may be tuned by varying the amount of therapeutics loaded within the fluid-absorbent particles, the density of the fluid-absorbent particles within the wound contact layer, the perforation size, and the thickness of the wound contact layer.

An absorbent article includes an absorbent member positioned between a topsheet and a backsheet. The absorbent member contains at least one layer that includes superabsorbent particles containing a porous network that includes a plurality of nanopores having an average cross-sectional dimension of from about 10 to about 500 nanometers, wherein the superabsorbent particles exhibit a Vortex Time of about 80 seconds or less and a free swell gel bed permeability (GBP) of 5 darcys or more, of 10 darcys or more, of 60 darcys or more, or of 90 darcys or more.

An absorbent article includes an absorbent member positioned between a topsheet and a backsheet. The absorbent member contains at least one layer that includes superabsorbent particles containing a porous network that includes a plurality of nanopores having an average cross-sectional dimension of from about 10 to about 500 nanometers, wherein the superabsorbent particles exhibit a Vortex Time of about 80 seconds or less and a free swell gel bed permeability (GBP) of 5 darcys or more, of 10 darcys or more, of 60 darcys or more, or of 90 darcys or more.